In cancer-related VTE, DOACs reduce recurrent VTE compared with LMWH; groups do not differ for major bleeding.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 33316186.
- Also identified by DOI 10.7326/ACPJ202012150-062.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Haykal T, Zayed Y, Deliwala S, et al. <b>Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: an updated meta-analysis of randomized controlled trials.</b> Thromb Res. 2020;194:57-65. 32788122.
Medical subject headings
- Neoplasms
- Venous Thromboembolism